CD44 and familial pancreatic carcinoma: Shah and colleagues [30] from M.D. Anderson showed that pancreatic cancer cell lines that selectively grew in culture media containing therapeutic doses of gemcitabine increased in expression of the stem cell markers CD24, CD44, and ESA.